Flow cytometric analysis of breast cancer resistance protein expression and function
Hans Minderman(Roswell Park Comprehensive Cancer Center), Maria R. Baer(University of Maryland, Baltimore), Attaya Suvannasankha(Indiana University Health), George L. Scheffer(University of Amsterdam), Rik J. Scheper(Unknown), Robert W. Robey(National Institutes of Health), Kieran L. O’Loughlin(Roswell Park Comprehensive Cancer Center)
Cited by 86
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795
<i>IDH1</i> and <i>IDH2</i> Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
|Journal of Clinical Oncology|2010|764
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
|Proceedings of the National Academy of Sciences|1994|691
The drug resistance-related protein LRP is the human major vault protein
|Nature Medicine|1995|619